D
Arbutus Biopharma Corporation ABUS
$3.59 $0.0050.14% NASDAQ
Recommendation
Prev Close
$3.49
Volume
148,207
Avg Vol (90D)
793,854
Market Cap
$669.03M
Dividend & Yield
--
52-Week Range
$2.71 - $4.73
P/E (TTM)
--
EPS (TTM)
-$0.2922
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Arbutus Biopharma (ABUS, $3.58) price may drop as it broke higher Bollinger Band on Aug 21, 2025
8/22/2025 - Tickeron - Technical Analysis
Arbutus Biopharma (ABUS, $3.58) RSI Indicator left the overbought zone on August 21, 2025
8/22/2025 - Tickeron - Technical Analysis
What is Chardan Capital's Forecast for ABUS FY2025 Earnings?
8/16/2025 - MarketBeat
Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?
8/14/2025 - Zacks Investment Research
Arbutus Biopharma (NASDAQ:ABUS) Given "Buy" Rating at Chardan Capital
8/12/2025 - MarketBeat
Chardan Capital Maintains Buy Rating for Arbutus Biopharma (ABUS) ABUS Stock News
8/11/2025 - GuruFocus
Arbutus Biopharma (NASDAQ:ABUS) Releases Earnings Results, Beats Estimates By $0.03 EPS
8/10/2025 - MarketBeat
Arbutus Biopharma (NASDAQ:ABUS) Stock Rating Upgraded by Wall Street Zen
8/10/2025 - MarketBeat
Arbutus Biopharma (ABUS, $3.4) RSI Indicator left the overbought zone on August 07, 2025
8/8/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $3.47) price may drop as it broke higher Bollinger Band on Aug 06, 2025
8/7/2025 - Tickeron - Technical Analysis
Arbutus Biopharma (ABUS, $3.47) RSI Indicator left the overbought zone on August 06, 2025
8/7/2025 - Tickeron - Technical Analysis
Arbutus (ABUS) Q2 Revenue Surges 529%
8/6/2025 - Fool.com Headlines
Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates
8/6/2025 - Zacks Investment Research
Arbutus Biopharma Corp Reports Q2 2025 Earnings: EPS of $0.01 and Revenue of $10. ...
8/6/2025 - GuruFocus
Arbutus Biopharma reports Q2 EPS 1c vs (11c) last year
8/6/2025 - The Fly
Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update
8/6/2025 - Globe Newswire
Arbutus Biopharma (ABUS, $3.34) price moved above its 50-day Moving Average on August 04, 2025
8/5/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS) Expected to Announce Earnings on Thursday
7/31/2025 - MarketBeat
Arbutus Biopharma (ABUS, $3.3) price exceeded its 50-day Moving Average on July 29, 2025
7/30/2025 - Tickeron - Stocks
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Crosses Above 200-Day Moving Average - Here's Why
7/29/2025 - Ticker Report
Arbutus Biopharma (ABUS, $3.35) price moved above its 50-day Moving Average on July 28, 2025
7/29/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $3.23) Stochastic Oscillator left the oversold zone on July 23, 2025
7/24/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $3.23) Moving Average Convergence Divergence (MACD) Histogram turned positive on July 23, 2025
7/24/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $3.15) entered Downtrend as Momentum indicator drops below 0 level on Jul 22, 2025
7/23/2025 - Tickeron - Stocks
Arbutus Biopharma's AB-101 Study: A Potential Game-Changer in Chronic Hepatitis B Treatment
7/18/2025 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$15.42M
EBITDA (TTM)
-$43.24M
EBIT (TTM)
-$44.25M
Net Income (TTM)
-$54.25M
Balance Sheet
Total Assets (Q)
$103.27M
Total Debt (Q)
$5.00M
Total Liabilities (Q)
$20.29M
Book Value Per Share (Q)
$0.433
Cash Flow
Cash from Operations (TTM)
-$60.19M
Cash from Investing (TTM)
$28.39M
Cash from Financing (TTM)
$6.43M
Net Change in Cash (TTM)
-$25.38M
Filings
Filing Date
Wednesday, August 6, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
0.31
7-Day Total Return
5.44%
30-Day Total Return
9.30%
60-Day Total Return
3.91%
90-Day Total Return
14.17%
Year to Date Total Return
8.97%
1-Year Total Return
-7.36%
2-Year Total Return
74.88%
3-Year Total Return
56.55%
5-Year Total Return
12.74%
52-week Low
Apr 09, 2025 - $2.71
52-week High
Sep 09, 2024 - $4.73
Valuation
Market Cap
$669.03M - Small Cap
Enterprise Value
$575.94M
Price/Sales (TTM)
43.57
Price/Book (Q)
8.06
Dividends and Shares
Shares Outstanding
192.40
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.arbutusbio.com
Phone Number
267 469 0914
Address
701 Veterans Circle
Warminster, PA 18974
Country
United States
Year Founded
2005
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline... more
NASDAQ 08/22/2025 10:10AM Eastern Quotes delayed